Tag: Treatment
-
There's No One-Size-Fits-All for Treating Older Adults with Cancer, According to New NCCN Patient Resource
New guideline for patients and caregivers explains the importance of assessments to tailor cancer care to every person, regardless of age. PLYMOUTH MEETING, Pa., Sept. 17, 2026 /PRNewswire/ — Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—is publishi…
-
NEW POLL: D.C. Policy Influencers, Small Business Owners and American Voters Demand U.S. Companies Receive Fair Treatment by Foreign Governments
Bipartisan majorities warn that U.S. lawmakers cannot tolerate discriminatory regulations by foreign countries that put American jobs, exports, and small businesses at risk.78% of the American public say they would be more likely to support policymakers who defend American businesses overseas, inclu…
-
Dr. Amita Shah from Manipal Hospital Gurugram becomes First Gynaecologist in India to perform 41 Robotic Surgeries in 90 Days
The achievement comes as Dr. Amita Shah successfully treats complex endometriosis cases using advanced robot-assisted and minimally invasive techniques with a focus on fertility preservations GURUGRAM, India, Sept. 11, 2026 /PRNewswire/ — In a significant advancement in women’s healthcare, Manipal …
-
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life – Spinal Cord Research Foundation.SCHLIEREN, Switzerland, Sept. 2, 2026 /PRNewswire/ — NovaGo Therapeutics AG, a clini…
-
Super MOXI® by Sciton Ushers in a New Era of Head-to-Toe Skin Revitalization
PALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ — Sciton Inc., a pioneer and leader in medical and aesthetic laser and light-based technologies, today announced the launch of Super MOXI® with High Density (HD) Delivery™, a major evolution of its award-winning MOXI® laser that brings new speed, versat…
-
Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
PALMA DE MALLORCA, Spain, July 24, 2026 /PRNewswire/ — Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the company’s Phase 2b/3 clinical trial of its …
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.